Therefore, the activation of the Nrf2/HO-1 axis may have potential inhibitory effects on colon cancer proliferation and metastasis, highlighting its prospective significance as a therapeutic target for metastatic colon cancer. This evidence concerns the gene NFE2L2 and malignant colon neoplasm.